Nijman HW - Search Results

1

B lymphocytes secrete antigen-presenting vesicles.

Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, Geuze HJ. Raposo G, et al. Among authors: nijman hw. J Exp Med. 1996 Mar 1;183(3):1161-72. doi: 10.1084/jem.183.3.1161. J Exp Med. 1996. PMID: 8642258 Free PMC article.

2

Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells.

Nijman HW, Kleijmeer MJ, Ossevoort MA, Oorschot VM, Vierboom MP, van de Keur M, Kenemans P, Kast WM, Geuze HJ, Melief CJ. Nijman HW, et al. J Exp Med. 1995 Jul 1;182(1):163-74. doi: 10.1084/jem.182.1.163. J Exp Med. 1995. PMID: 7790816 Free PMC article.

3

Functional and ultrastructural aspects of antigen processing by dendritic cells.

Ossevoort MA, Kleijmeer MJ, Nijman HW, Geuze HJ, Kast WM, Melief CJ. Ossevoort MA, et al. Among authors: nijman hw. Adv Exp Med Biol. 1995;378:227-31. doi: 10.1007/978-1-4615-1971-3_51. Adv Exp Med Biol. 1995. PMID: 8526062 Review. No abstract available.

4

Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes.

Vierboom MP, Nijman HW, Offringa R, van der Voort EI, van Hall T, van den Broek L, Fleuren GJ, Kenemans P, Kast WM, Melief CJ. Vierboom MP, et al. Among authors: nijman hw. J Exp Med. 1997 Aug 29;186(5):695-704. doi: 10.1084/jem.186.5.695. J Exp Med. 1997. PMID: 9271585 Free PMC article.

5

Induction and characterization of cytotoxic T-lymphocytes recognizing a mutated p21ras peptide presented by HLA-A*0201.

Van Elsas A, Nijman HW, Van der Minne CE, Mourer JS, Kast WM, Melief CJ, Schrier PI. Van Elsas A, et al. Among authors: nijman hw. Int J Cancer. 1995 May 4;61(3):389-96. doi: 10.1002/ijc.2910610319. Int J Cancer. 1995. PMID: 7729952

6

Characterization of cytotoxic T lymphocyte epitopes of a self-protein, p53, and a non-self-protein, influenza matrix: relationship between major histocompatibility complex peptide binding affinity and immune responsiveness to peptides.

Nijman HW, Houbiers JG, van der Burg SH, Vierboom MP, Kenemans P, Kast WM, Melief CJ. Nijman HW, et al. J Immunother Emphasis Tumor Immunol. 1993 Aug;14(2):121-6. J Immunother Emphasis Tumor Immunol. 1993. PMID: 7506574

7

Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes.

Nijman HW, Houbiers JG, Vierboom MP, van der Burg SH, Drijfhout JW, D'Amaro J, Kenemans P, Melief CJ, Kast WM. Nijman HW, et al. Eur J Immunol. 1993 Jun;23(6):1215-9. doi: 10.1002/eji.1830230603. Eur J Immunol. 1993. PMID: 7684681

8

p53, a potential target for tumor-directed T cells.

Nijman HW, Van der Burg SH, Vierboom MP, Houbiers JG, Kast WM, Melief CJ. Nijman HW, et al. Immunol Lett. 1994 May;40(2):171-8. doi: 10.1016/0165-2478(94)90189-9. Immunol Lett. 1994. PMID: 8088874

9

In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53.

Houbiers JG, Nijman HW, van der Burg SH, Drijfhout JW, Kenemans P, van de Velde CJ, Brand A, Momburg F, Kast WM, Melief CJ. Houbiers JG, et al. Among authors: nijman hw. Eur J Immunol. 1993 Sep;23(9):2072-7. doi: 10.1002/eji.1830230905. Eur J Immunol. 1993. PMID: 8370389

10

T cell infiltration and MHC I and II expression in the presence of tumor antigens: An immunohistochemical study in patients with serous epithelial ovarian cancer.

Nijman HW, van Diest PJ, Poort-Keesom RJ, von Mensdorff-Pouilly S, Verstraeten RA, Kummer A, Meijer CJ, Melief CJ, Hilgers J, Kenemans P. Nijman HW, et al. Eur J Obstet Gynecol Reprod Biol. 2001 Jan;94(1):114-20. doi: 10.1016/s0301-2115(00)00294-3. Eur J Obstet Gynecol Reprod Biol. 2001. PMID: 11134836

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

197 results

Search Page